| 2025-02-07 | +0.91 % |
|
| 2025-02-06 | +3.35 % |
|
| 2025-02-05 | +1.95 % |
|
| 2025-02-04 | +1.93 % |
|
| 2025-02-03 | -0.08 % |
|
| 2025-01-27 | +2.9 % |
|
| 2025-01-21 | +2.29 % |
|
| 2025-01-14 | -6.59 % |
|
| 2025-01-13 | -0.3 % |
|
| 2025-01-10 | +1.61 % |
|
| 2025-01-06 | -2.16 % |
|
| 2025-01-03 | +0.5 % |
|
| 2024-12-31 | -0.24 % |
- Eli Lilly & Co. (LLY) stock fell by 0.24% recently, potentially due to ongoing concerns in the healthcare sector and broader market volatility affecting investor sentiment.
- Eli Lilly & Co (LLY) stock experienced a decline of 0.24%, which was contributed to broader market trends and investor sentiment, alongside recent adjustments in stock valuations surrounding the healthcare sector.
- Eli Lilly & Co (LLY) stock declined by 0.24% recently, possibly due to overall market trends, news affecting the pharmaceutical sector, or investor reactions to recent changes in trading activity.
- Eli Lilly & Co (LLY) stock experienced a decline of 0.24%, which may be attributed to broader market trends or investor reactions to external economic factors, rather than specific company news.
- Eli Lilly & Co. (LLY) stock experienced a decrease of 0.24% due to disappointing quarterly earnings, where the company missed analysts' expectations for EPS and revenue, which could have affected investor confidence.
|
| 2024-12-13 | +0.87 % |
|
| 2024-12-10 | -0.5 % |
|
| 2024-12-06 | +0.13 % |
|
| 2024-11-21 | -0.46 % |
|
| 2024-11-07 | +2.71 % |
|
| 2024-11-05 | -0.01 % |
|
| 2024-11-04 | -1.56 % |
|
| 2024-10-30 | -6.28 % |
|
| 2024-10-29 | +0.89 % |
|
| 2024-10-23 | -0.65 % |
|
| 2024-10-22 | +0.33 % |
|
| 2024-10-09 | +0.66 % |
|
| 2024-10-02 | +0.75 % |
|
| 2024-10-01 | -0.16 % |
|
| 2024-09-30 | +0.93 % |
|
| 2024-09-27 | -3.47 % |
|
| 2024-09-20 | +0.7 % |
|
| 2024-09-19 | +1.11 % |
|
| 2024-09-12 | +1.53 % |
|
| 2024-09-10 | -0.77 % |
|
| 2024-09-09 | +0.62 % |
|
| 2024-09-06 | -1.1 % |
|
| 2024-09-04 | -1.07 % |
|
